On March 31, 2017 the FDA issued a notice regarding EpiPen 2-Pak Auto-Injectors 0.3 mg and EpiPen Jr. 2-Pak Auto-Injectors 0.15 mg. The potential defect could make the device difficult to activate. As a result the products with the lot numbers listed below are RECALLED.
Please note that NOT ALL EpiPens have been recalled. If you have a concern, please call our office.
New Jersey Family- the essential source for NJ moms